Exhibit 23.1

               Consent of Ernst & Young LLP, Independent Auditor

   We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) of Cell Therapeutics, Inc. and related
Prospectus of Cell Therapeutics, Inc. for the registration of 6,198,087 shares
of its common stock and to the incorporation by reference therein of our report
dated February 25, 2000, with respect to the consolidated financial statements
of Cell Therapeutics, Inc. included in its Current Report on Form 8-K dated
March 2, 2000, filed with the Securities and Exchange Commission.

Seattle, Washington
March 17, 2000